(Q36639914)

15 August 2017

1 reference

title

Current and future use of positron emission tomography (PET) in breast cancer (English)

1 reference

positron emission tomography

15 August 2017

main subject

1 reference

David A Mankoff

1 reference

15 August 2017

William B Eubank

series ordinal

1 reference

15 August 2017

language of work or name

1 reference

1 April 2006

1 reference

Journal of Mammary Gland Biology and Neoplasia

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

125-136

1 reference

Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-006-9019-Z

Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-006-9019-Z

Breast cancer: PET imaging of estrogen receptors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-006-9019-Z

21 January 2018

1 reference

12 December 2020

Imaging hypoxia and angiogenesis in tumors

1 reference

12 December 2020

Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer

1 reference

12 December 2020

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).

1 reference

12 December 2020

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

1 reference

12 December 2020

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

1 reference

12 December 2020

Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?

1 reference

12 December 2020

Imaging of apoptosis (programmed cell death) with 99mTc annexin V

1 reference

12 December 2020

Evolving role of positron emission tomography in breast cancer imaging

1 reference

12 December 2020

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

1 reference

12 December 2020

Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method

1 reference

12 December 2020

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

12 December 2020

Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography

1 reference

12 December 2020

18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy

1 reference

12 December 2020

Steroid Hormone Receptors in Human Breast Cancer

1 reference

12 December 2020

PET imaging of cellular proliferation

1 reference

12 December 2020

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography

1 reference

12 December 2020

Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients

1 reference

12 December 2020

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.

1 reference

12 December 2020

Pilot Feasibility Study to Assess the Utility of PET Scanning in the Pre-Operative Evaluation of Internal Mammary Nodes in Breast Cancer Patients Presenting with Medial Hemisphere Tumors

1 reference

12 December 2020

[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow

1 reference

12 December 2020

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

12 December 2020

Should internal mammary nodes be sampled in the sentinel lymph node era?

1 reference

12 December 2020

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer

1 reference

12 December 2020

PET/CT scanner instrumentation, challenges, and solutions

1 reference

12 December 2020

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.

1 reference

12 December 2020

Bone metastases: pathophysiology and management policy

1 reference

12 December 2020

A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases

1 reference

12 December 2020

Current and future uses of positron emission tomography in breast cancer imaging

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival

1 reference

12 December 2020

Changes in Glucose Metabolism and Blood Flow Following Chemotherapy for Breast Cancer

1 reference

12 December 2020

Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience

1 reference

12 December 2020

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo

1 reference

12 December 2020

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer

1 reference

12 December 2020

Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy

1 reference

12 December 2020

Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates

1 reference

12 December 2020

Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer

1 reference

12 December 2020

Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer

1 reference

12 December 2020

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

12 December 2020

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients

1 reference

12 December 2020

Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner

1 reference

12 December 2020

Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis

1 reference

12 December 2020

18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer

1 reference

12 December 2020

Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective

1 reference

12 December 2020

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging

1 reference

12 December 2020

Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.

1 reference

12 December 2020

[18F]fluoroestradiol radiation dosimetry in human PET studies

1 reference

12 December 2020

The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer

1 reference

12 December 2020

Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group

1 reference

12 December 2020

The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.

1 reference

12 December 2020

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

12 December 2020

Tumor hypoxia and gene expression--implications for malignant progression and therapy

1 reference

12 December 2020

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.

1 reference

12 December 2020

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.

1 reference

12 December 2020

A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier

1 reference

12 December 2020

Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.

1 reference

12 December 2020

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

1 reference

12 December 2020

PET radiopharmaceuticals: state-of-the-art and future prospects

1 reference

12 December 2020

Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography

1 reference

12 December 2020

Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience

1 reference

12 December 2020

FDG-PET in monitoring therapy of breast cancer

1 reference

12 December 2020

PET/CT and breast cancer

1 reference

12 December 2020

New targeted therapies in breast cancer

1 reference

12 December 2020

FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers

1 reference

12 December 2020

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

1 reference

12 December 2020

Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography

1 reference

12 December 2020

Method for combined FDG-PET and radiographic imaging of primary breast cancers

1 reference

12 December 2020

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

12 December 2020

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report

1 reference

12 December 2020

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

1 reference

12 December 2020

Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

Use of positron emission tomography in anticancer drug development

1 reference

12 December 2020

Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.

1 reference

12 December 2020

18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome.

1 reference

12 December 2020

PET scan in the staging of non-small cell lung cancer

1 reference

12 December 2020

PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study

1 reference

12 December 2020

Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.

1 reference

12 December 2020

10.1007/S10911-006-9019-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference